175 related articles for article (PubMed ID: 20164856)
1. Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenoviruses.
Sharma A; Tandon M; Ahi YS; Bangari DS; Vemulapalli R; Mittal SK
Gene Ther; 2010 May; 17(5):634-42. PubMed ID: 20164856
[TBL] [Abstract][Full Text] [Related]
2. Circumvention of vector-specific neutralizing antibody response by alternating use of human and non-human adenoviruses: implications in gene therapy.
Moffatt S; Hays J; HogenEsch H; Mittal SK
Virology; 2000 Jun; 272(1):159-67. PubMed ID: 10873758
[TBL] [Abstract][Full Text] [Related]
3. Porcine adenoviral vectors evade preexisting humoral immunity to adenoviruses and efficiently infect both human and murine cells in culture.
Bangari DS; Mittal SK
Virus Res; 2004 Oct; 105(2):127-36. PubMed ID: 15351486
[TBL] [Abstract][Full Text] [Related]
4. Comparative transduction efficiencies of human and nonhuman adenoviral vectors in human, murine, bovine, and porcine cells in culture.
Bangari DS; Shukla S; Mittal SK
Biochem Biophys Res Commun; 2005 Feb; 327(3):960-6. PubMed ID: 15649439
[TBL] [Abstract][Full Text] [Related]
5. Porcine adenovirus serotype 3 internalization is independent of CAR and alphavbeta3 or alphavbeta5 integrin.
Bangari DS; Mittal SK
Virology; 2005 Feb; 332(1):157-66. PubMed ID: 15661148
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse model.
Sharma A; Bangari DS; Tandon M; Pandey A; HogenEsch H; Mittal SK
Virology; 2009 Mar; 386(1):44-54. PubMed ID: 19211122
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of innate immunity and vector toxicity following inoculation of bovine, porcine or human adenoviral vectors in a mouse model.
Sharma A; Bangari DS; Tandon M; Hogenesch H; Mittal SK
Virus Res; 2010 Oct; 153(1):134-42. PubMed ID: 20659505
[TBL] [Abstract][Full Text] [Related]
8. Persistence and the state of bovine and porcine adenoviral vector genomes in human and nonhuman cell lines.
Sharma A; Bangari DS; Vemula SV; Mittal SK
Virus Res; 2011 Nov; 161(2):181-7. PubMed ID: 21864589
[TBL] [Abstract][Full Text] [Related]
9. Bovine adenovirus type 3 internalization is independent of primary receptors of human adenovirus type 5 and porcine adenovirus type 3.
Bangari DS; Sharma A; Mittal SK
Biochem Biophys Res Commun; 2005 Jun; 331(4):1478-84. PubMed ID: 15883040
[TBL] [Abstract][Full Text] [Related]
10. Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype.
Sparer TE; Wynn SG; Clark DJ; Kaplan JM; Cardoza LM; Wadsworth SC; Smith AE; Gooding LR
J Virol; 1997 Mar; 71(3):2277-84. PubMed ID: 9032363
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and Cross-Reactivity of Rhesus Adenoviral Vectors.
Iampietro MJ; Larocca RA; Provine NM; Abbink P; Kang ZH; Bricault CA; Barouch DH
J Virol; 2018 Jun; 92(11):. PubMed ID: 29563285
[TBL] [Abstract][Full Text] [Related]
12. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.
Juillard V; Villefroy P; Godfrin D; Pavirani A; Venet A; Guillet JG
Eur J Immunol; 1995 Dec; 25(12):3467-73. PubMed ID: 8566039
[TBL] [Abstract][Full Text] [Related]
13. Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor.
Mahon BP; Katrak K; Nomoto A; Macadam AJ; Minor PD; Mills KH
J Exp Med; 1995 Apr; 181(4):1285-92. PubMed ID: 7699320
[TBL] [Abstract][Full Text] [Related]
14. Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice.
Nguyen HH; van Ginkel FW; Vu HL; Novak MJ; McGhee JR; Mestecky J
J Virol; 2000 Jun; 74(12):5495-501. PubMed ID: 10823854
[TBL] [Abstract][Full Text] [Related]
15. Trimeric knob protein specifically distinguishes neutralizing antibodies to different human adenovirus species: potential application for adenovirus seroepidemiology.
Yu B; Dong J; Wang C; Wang Z; Gao L; Zhang H; Wu J; Kong W; Yu X
J Gen Virol; 2014 Jul; 95(Pt 7):1564-1573. PubMed ID: 24764358
[TBL] [Abstract][Full Text] [Related]
16. "Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung.
Croyle MA; Chirmule N; Zhang Y; Wilson JM
J Virol; 2001 May; 75(10):4792-801. PubMed ID: 11312351
[TBL] [Abstract][Full Text] [Related]
17. Sequential administration of bovine and human adenovirus vectors to overcome vector immunity in an immunocompetent mouse model of breast cancer.
Tandon M; Sharma A; Vemula SV; Bangari DS; Mittal SK
Virus Res; 2012 Jan; 163(1):202-11. PubMed ID: 21971215
[TBL] [Abstract][Full Text] [Related]
18. Bovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of pre-existing immunity against human adenovirus.
Singh N; Pandey A; Jayashankar L; Mittal SK
Mol Ther; 2008 May; 16(5):965-71. PubMed ID: 18301400
[TBL] [Abstract][Full Text] [Related]
19. Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what's important?
Fausther-Bovendo H; Kobinger GP
Hum Vaccin Immunother; 2014; 10(10):2875-84. PubMed ID: 25483662
[TBL] [Abstract][Full Text] [Related]
20. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses.
Yang Y; Li Q; Ertl HC; Wilson JM
J Virol; 1995 Apr; 69(4):2004-15. PubMed ID: 7884845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
